Literature DB >> 30685995

Vaspin, neutrophil gelatinase-associated lipocalin and apolipoprotein levels in patients with psoriatic arthritis.

S Colak, A Omma, S C Sandikci, C Yucel, T Omma, T Turhan.   

Abstract

OBJECTIVES: To examine the relationship between disease activity and vaspin, neutrophil gelatinase-associated lipocalin (NGAL) and apolipoprotein levels in patients with psoriatic arthritis (PsA).
BACKGROUND: Psoriatic arthritis (PsA) is a chronic inflammatory arthritis, which is related with psoriasis. Adipokines are the mediators which play a role in metabolic homeostasis and inflammatory conditions.
METHODS: The levels of vaspin, NGAL, apolipoproteins and their correlations with disease activity were compared in 50 psoriatic arthritis patients and 36 healthy controls.
RESULTS: The levels of vaspin, NGAL and apolipoprotein B/A1 ratio were significantly higher in the patient group (p 0.05).
CONCLUSION: This is the first study to have compared vaspin and NGAL levels in patients with PsA. Vaspin and NGAL can be used as a biomarker in PsA. Vaspin, NGAL and dyslipoproteinemia are not correlated with disease activity (Tab. 3, Ref. 63).

Entities:  

Keywords:  apolipoprotein; disease activity; neutrophil gelatinase-associated lipocalin; psoriatic arthritis vaspin.

Mesh:

Substances:

Year:  2019        PMID: 30685995     DOI: 10.4149/BLL_2019_010

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  7 in total

1.  Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results.

Authors:  Paulina Kiluk; Anna Baran; Tomasz W Kaminski; Magdalena Maciaszek; Iwona Flisiak
Journal:  Postepy Dermatol Alergol       Date:  2021-02-07       Impact factor: 1.664

2.  Association of Serum Lipocalin-2 Concentrations with Psoriasis and Psoriatic Arthritis: An Updated Meta-Analysis.

Authors:  Dingjian Wang; Lanlan Fang; Guixia Pan
Journal:  Dis Markers       Date:  2019-08-05       Impact factor: 3.434

Review 3.  The Adipokine Network in Rheumatic Joint Diseases.

Authors:  Mar Carrión; Klaus W Frommer; Selene Pérez-García; Ulf Müller-Ladner; Rosa P Gomariz; Elena Neumann
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

Review 4.  Adipokines and Autoimmunity in Inflammatory Arthritis.

Authors:  Elena Neumann; Rebecca Hasseli; Selina Ohl; Uwe Lange; Klaus W Frommer; Ulf Müller-Ladner
Journal:  Cells       Date:  2021-01-22       Impact factor: 6.600

Review 5.  Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis.

Authors:  Sabrina Porta; Matilde Otero-Losada; Rodolfo A Kölliker Frers; Vanesa Cosentino; Eduardo Kerzberg; Francisco Capani
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

Review 6.  Lipocalin 2 Participates in the Epidermal Differentiation and Inflammatory Processes of Psoriasis.

Authors:  Kaixuan Ren; Yumin Xia
Journal:  J Inflamm Res       Date:  2022-03-31

Review 7.  Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases.

Authors:  Lucia Recinella; Giustino Orlando; Claudio Ferrante; Annalisa Chiavaroli; Luigi Brunetti; Sheila Leone
Journal:  Front Physiol       Date:  2020-10-30       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.